[HTML][HTML] Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
The present review details a chronological description of the events that took place during
the development of mesoporous materials, their different synthetic routes and their use as …
the development of mesoporous materials, their different synthetic routes and their use as …
Alzheimer's disease and its treatment by different approaches: A review
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …
development and interrupts neurocognitive function. This neuropathological condition is …
Mesoporous silica and organosilica nanoparticles: physical chemistry, biosafety, delivery strategies, and biomedical applications
Predetermining the physico‐chemical properties, biosafety, and stimuli‐responsiveness of
nanomaterials in biological environments is essential for safe and effective biomedical …
nanomaterials in biological environments is essential for safe and effective biomedical …
[HTML][HTML] Nanotechnology-based drug delivery for central nervous system disorders
Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …
[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …
characterized by cognitive deficits, with loss of recent memory and language ability …
Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease
In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …
[HTML][HTML] Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Abstract Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time,
exerting a significant impact on physical and mental health and leading to death. The …
exerting a significant impact on physical and mental health and leading to death. The …
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Q Ouyang, Y Meng, W Zhou, J Tong… - Journal of drug …, 2022 - Taylor & Francis
Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and its
incidence is increasing due to the ageing population. Currently, the main limitations of AD …
incidence is increasing due to the ageing population. Currently, the main limitations of AD …
Multidisciplinary role of mesoporous silica nanoparticles in brain regeneration and cancers: From crossing the blood–brain barrier to treatment
S Mendiratta, M Hussein, HA Nasser… - Particle & Particle …, 2019 - Wiley Online Library
Mesoporous silica nanoparticles (MSNs) have gained wide attention for their role in
biomedicine and as drug delivery vehicles. Their structural tunability, high surface area, and …
biomedicine and as drug delivery vehicles. Their structural tunability, high surface area, and …
[HTML][HTML] Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …